Skip to main content

Navigation group

Type at least 3 characters
595 articles

Articles

Study Protocol

Published on 28 Aug 2020

The One Health Consortium: Design of a Phase I Clinical Trial to Evaluate M032, a Genetically Engineered HSV-1 Expressing IL-12, in Combination With a Checkpoint Inhibitor in Canine Patients With Sporadic High Grade Gliomas

in Neurosurgery

  • M. R. Chambers
  • R. Timothy Bentley
  • David K. Crossman
  • Jeremy B. Foote
  • Jey W. Koehler
  • James M. Markert
  • Nidal B. Omar
  • Simon R. Platt
  • D. Mitchell Self
  • Andy Shores
The One Health Consortium: Design of a Phase I Clinical Trial to Evaluate M032, a Genetically Engineered HSV-1 Expressing IL-12, in Combination With a Checkpoint Inhibitor in Canine Patients With Sporadic High Grade Gliomas
Frontiers in Surgery
doi 10.3389/fsurg.2020.00059
  • 5,454 views
  • 8 citations